secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2025-09-03T23:59:59+00:00
Accession:  0001193125-25-194481
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kymera Therapeutics appoints Brian Adams as Chief Legal Officer; Ellen Chiniara retires
--------------------------------------------------------------------------------

- Ellen Chiniara, Chief Legal Officer, retires effective Sept 3, 2025; departure not due to any disagreement with the company.
- Brian Adams appointed Chief Legal Officer and Corporate Secretary, effective Sept 3, 2025.
- Adams previously served as CLO of Relay Therapeutics and held senior legal roles at Keryx, Algeta, AVEO, and Genzyme.
- Chiniara receives no severance; she will focus on board service and mentoring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312525194481/0001193125-25-194481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312525194481/d94060d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-194481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer